<code id='3E702B02E2'></code><style id='3E702B02E2'></style>
    • <acronym id='3E702B02E2'></acronym>
      <center id='3E702B02E2'><center id='3E702B02E2'><tfoot id='3E702B02E2'></tfoot></center><abbr id='3E702B02E2'><dir id='3E702B02E2'><tfoot id='3E702B02E2'></tfoot><noframes id='3E702B02E2'>

    • <optgroup id='3E702B02E2'><strike id='3E702B02E2'><sup id='3E702B02E2'></sup></strike><code id='3E702B02E2'></code></optgroup>
        1. <b id='3E702B02E2'><label id='3E702B02E2'><select id='3E702B02E2'><dt id='3E702B02E2'><span id='3E702B02E2'></span></dt></select></label></b><u id='3E702B02E2'></u>
          <i id='3E702B02E2'><strike id='3E702B02E2'><tt id='3E702B02E2'><pre id='3E702B02E2'></pre></tt></strike></i>

          focus

          focus

          author:hotspot    Page View:39765
          Pharmacy shelves
          A conservative group advocating against changing how pharmacy middlemen operate spent more than $1 million on lobbying last quarter. GEORGE FREY/AFP via Getty Images

          WASHINGTON — A conservative group advocating against changing how pharmacy middlemen operate spent more than $1 million on lobbying last quarter — its highest-ever spend by far, according to federal filings.

          The Council for Citizens Against Government Waste spent $1.1 million on lobbying last quarter, and only employed a single lobbyist. That’s 22 times the $50,000 it spent in the same quarter last year. Its prior spending record was $700,000, from the start of 2020.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          focus

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M
          Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

          CytokineticsCEORobertBlumspokelastweekatatalkduringSTAT’sBreakthroughSummitWestinSanFrancisco.SarahG

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

          2:50GerryTurner,thefirst"GoldenBachelor"posesforthispromotionalphotofortheupcomingshow.BrianBowenSmi